Pharma-Bio Serv (PBSV) Income from Continuing Operations (2010 - 2026)
Pharma-Bio Serv (PBSV) reported Income from Continuing Operations of 232986.0 for Q2 2026, up 144.34% year-over-year from 95353.0 in Q2 2025, and up 609.03% on a QoQ basis from 32860.0 in Q1 2026.
Pharma-Bio Serv (PBSV) Income from Continuing Operations (2010 - 2026) Analysis & Trends
Pharma-Bio Serv's Income from Continuing Operations history runs 17 years deep, the most recent figure standing at 232986.0 for Q2 2026.
- Income from Continuing Operations for Q2 2026 came in at 232986.0, up 144.34% year-over-year; the trailing twelve-month figure through Apr 2026 was 51936.0 (up 127.45% YoY), and the FY2025 annual result was 100463.0, up 87.08% from the prior year.
- Income from Continuing Operations came in at 232986.0 for Q2 2026 at Pharma-Bio Serv, up from 32860.0 in the prior quarter.
- In the past five years, Income from Continuing Operations ranged from a high of 526242.0 in Q3 2023 to a low of 309194.0 in Q3 2024.
- A 5-year average of 94170.56 and a median of 64106.5 in 2025 frame the typical range for Income from Continuing Operations.
- Across the five-year window, Income from Continuing Operations plunged 163.48% in 2024 and surged 284.96% in 2026, its largest moves.
- Over 5 years, Income from Continuing Operations stood at 173379.0 in 2022, then slumped by 127.19% to 47148.0 in 2023, then surged by 134.17% to 16111.0 in 2024, then tumbled by 100.63% to 102.0 in 2025, then soared by 228517.65% to 232986.0 in 2026.
- The last three Income from Continuing Operations figures came in at 232986.0 (Q2 2026), 32860.0 (Q1 2026), and 102.0 (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 24.83 Bn | 17.52 Bn | 662.02 Mn | 260.94 Mn |
| 2 | BrightSpring Health Services | 13.57 Bn | 12.69 Bn | 482.22 Mn | 74.28 Mn |
| 3 | Healthequity | 7.20 Bn | 6.93 Bn | 256.31 Mn | 69.42 Mn |
| 4 | Hinge Health | 5.42 Bn | 5.11 Bn | 154.23 Mn | 35.13 Mn |
| 5 | 10x Genomics | 4.46 Bn | 3.92 Bn | 106.18 Mn | -13.47 Mn |
| 6 | Doximity | 3.81 Bn | 3.06 Bn | 125.97 Mn | 19.11 Mn |
| 7 | Waystar Holding | 3.52 Bn | 3.36 Bn | 268.04 Mn | 43.32 Mn |
| 8 | Privia Health | 2.94 Bn | 2.57 Bn | 595.71 Mn | 3.71 Mn |
| 9 | Omnicell | 1.76 Bn | 1.59 Bn | 140.36 Mn | 11.41 Mn |
| 10 | Pharma-Bio Serv | - | - | 902,041.00 | 232,986.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 232,986.00 |
| Jan 31, 2026 | 32,860.00 |
| Oct 31, 2025 | -102.00 |
| Jul 31, 2025 | -213,808.00 |
| Apr 30, 2025 | 95,353.00 |
| Jan 31, 2025 | 8,536.00 |
| Oct 31, 2024 | 16,111.00 |
| Jul 31, 2024 | -309,194.00 |
| Apr 30, 2024 | -213,817.00 |
| Jan 31, 2024 | -270,719.00 |
| Oct 31, 2023 | -47,148.00 |
| Jul 31, 2023 | 526,242.00 |
| Apr 30, 2023 | 404,654.00 |
| Jan 31, 2023 | 426,432.00 |
| Oct 31, 2022 | 173,379.00 |
| Jul 31, 2022 | 288,034.00 |
| Apr 30, 2022 | 240,027.00 |
| Jan 31, 2022 | 305,244.00 |
| Oct 31, 2021 | -4.87 Mn |
| Jul 31, 2021 | 2.28 Mn |